Novo Nordisk Brings World's First Once-Weekly Basal Insulin Awiqli to India
Novo Nordisk India has launched Awiqli, the world's first once-weekly basal insulin, offering adults with diabetes a more convenient treatment option with fewer injections.
Diabetes Care | 10/07/2026 | By News Bureau | 146
Abbott Inaugurates New Global Manufacturing Facility in Ireland
The Kilkenny facility is part of a EUR 440 million investment in Ireland, which includes a significant expansion of the company’s Donegal site, where a further 200 jobs are being created.
Diabetes Care | 19/11/2024 | By Aishwarya | 875
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy